Xeris Biopharma Reports First Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| (NASDAQ: XERS) | Delayed: 9.77 -0.43 (4.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.20 | 52 Week High | $ | |||
| Open | $10.08 | 52 Week Low | $ | |||
| Day High | $10.39 | P/E | N/A | |||
| Day Low | $9.73 | EPS | $ | |||
| Volume | 2,367,073 | |||||
